(MO) Altria - Ratings and Ratios
Cigarettes, Cigars, Smokeless, Nicotine Pouches, E-Vapor
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.00% |
| Yield on Cost 5y | 14.40% |
| Yield CAGR 5y | 4.26% |
| Payout Consistency | 98.2% |
| Payout Ratio | 76.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 18.8% |
| Value at Risk 5%th | 28.8% |
| Relative Tail Risk | -6.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 27.95 |
| CAGR/Max DD | 1.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.483 |
| Beta | -0.023 |
| Beta Downside | 0.173 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.40% |
| Mean DD | 4.73% |
| Median DD | 4.08% |
Description: MO Altria December 02, 2025
Altria Group, Inc. (NYSE: MO) manufactures and markets a portfolio of combustible and oral tobacco products in the United States, including Marlboro cigarettes, Black & Mild cigars, Copenhagen and Skoal smokeless tobacco, the on! nicotine-pouch line, and NJOY ACE e-vapor devices, primarily sold through distributors and large retail chains.
Key recent metrics: 2023 net revenue was approximately $15.5 billion with an adjusted earnings-before-interest-tax-depreciation-amortization (EBITDA) margin near 30 %, reflecting strong pricing power despite a declining smoker base. The company’s dividend yield remains high at roughly 8 %, a core attraction for income-focused investors. Altria’s growth outlook hinges on the performance of reduced-risk products (RRPs) such as nicotine pouches, which currently account for about 5 % of total sales and are projected to reach double-digit contribution by 2026, while regulatory risk and shifting consumer preferences continue to shape the tobacco sector.
For a deeper, data-driven assessment of Altria’s valuation and risk profile, you might explore the analytical tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 8.87b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 1.39 > 1.0 |
| NWC/Revenue: -15.70% < 20% (prev -22.09%; Δ 6.38% < -1%) |
| CFO/TA 0.27 > 3% & CFO 9.36b > Net Income 8.87b |
| Net Debt (22.23b) to EBITDA (12.10b): 1.84 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.68b) vs 12m ago -1.12% < -2% |
| Gross Margin: 71.98% > 18% (prev 0.70%; Δ 7128 % > 0.5%) |
| Asset Turnover: 58.30% > 50% (prev 59.60%; Δ -1.29% > 0%) |
| Interest Coverage Ratio: 11.04 > 6 (EBITDA TTM 12.10b / Interest Expense TTM 1.07b) |
Altman Z'' 6.02
| A: -0.09 (Total Current Assets 5.12b - Total Current Liabilities 8.29b) / Total Assets 35.01b |
| B: 1.03 (Retained Earnings 36.12b / Total Assets 35.01b) |
| C: 0.34 (EBIT TTM 11.81b / Avg Total Assets 34.59b) |
| D: 0.91 (Book Value of Equity 34.34b / Total Liabilities 37.60b) |
| Altman-Z'' Score: 6.02 = AAA |
Beneish M -3.21
| DSRI: 0.86 (Receivables 249.0m/291.0m, Revenue 20.17b/20.36b) |
| GMI: 0.97 (GM 71.98% / 70.04%) |
| AQI: 0.95 (AQ_t 0.81 / AQ_t-1 0.85) |
| SGI: 0.99 (Revenue 20.17b / 20.36b) |
| TATA: -0.01 (NI 8.87b - CFO 9.36b) / TA 35.01b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
ValueRay F-Score (Strict, 0-100) 73.64
| 1. Piotroski: 6.50pt |
| 2. FCF Yield: 7.36% |
| 3. FCF Margin: 45.56% |
| 4. Debt/Equity: -9.71 |
| 5. Debt/Ebitda: 1.84 |
| 6. ROIC - WACC: 35.82% |
| 7. RoE: -304.5% |
| 8. Revenue Trend: -4.51% |
| 9. EPS Trend: 69.50% |
What is the price of MO shares?
Over the past week, the price has changed by +2.99%, over one month by +9.34%, over three months by +0.62% and over the past year by +26.27%.
Is MO a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 9
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the MO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62.6 | -0.6% |
| Analysts Target Price | 62.6 | -0.6% |
| ValueRay Target Price | 78.9 | 25.2% |
MO Fundamental Data Overview January 24, 2026
P/E Forward = 10.8932
P/S = 5.084
P/B = 27.3016
P/EG = 4.0147
Revenue TTM = 20.17b USD
EBIT TTM = 11.81b USD
EBITDA TTM = 12.10b USD
Long Term Debt = 24.13b USD (from longTermDebt, last quarter)
Short Term Debt = 1.57b USD (from shortTermDebt, last quarter)
Debt = 25.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.23b USD (from netDebt column, last quarter)
Enterprise Value = 124.75b USD (102.52b + Debt 25.70b - CCE 3.47b)
Interest Coverage Ratio = 11.04 (Ebit TTM 11.81b / Interest Expense TTM 1.07b)
EV/FCF = 13.58x (Enterprise Value 124.75b / FCF TTM 9.19b)
FCF Yield = 7.36% (FCF TTM 9.19b / Enterprise Value 124.75b)
FCF Margin = 45.56% (FCF TTM 9.19b / Revenue TTM 20.17b)
Net Margin = 43.98% (Net Income TTM 8.87b / Revenue TTM 20.17b)
Gross Margin = 71.98% ((Revenue TTM 20.17b - Cost of Revenue TTM 5.65b) / Revenue TTM)
Gross Margin QoQ = 72.60% (prev 72.78%)
Tobins Q-Ratio = 3.56 (Enterprise Value 124.75b / Total Assets 35.01b)
Interest Expense / Debt = 1.08% (Interest Expense 278.0m / Debt 25.70b)
Taxrate = 22.76% (700.0m / 3.08b)
NOPAT = 9.12b (EBIT 11.81b * (1 - 22.76%))
Current Ratio = 0.62 (Total Current Assets 5.12b / Total Current Liabilities 8.29b)
Debt / Equity = -9.71 (negative equity) (Debt 25.70b / totalStockholderEquity, last quarter -2.65b)
Debt / EBITDA = 1.84 (Net Debt 22.23b / EBITDA 12.10b)
Debt / FCF = 2.42 (Net Debt 22.23b / FCF TTM 9.19b)
Total Stockholder Equity = -2.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 25.64% (Net Income 8.87b / Total Assets 35.01b)
RoE = -304.5% (negative equity) (Net Income TTM 8.87b / Total Stockholder Equity -2.91b)
RoCE = 55.66% (EBIT 11.81b / Capital Employed (Equity -2.91b + L.T.Debt 24.13b))
RoIC = 40.65% (NOPAT 9.12b / Invested Capital 22.44b)
WACC = 4.83% (E(102.52b)/V(128.22b) * Re(5.83%) + D(25.70b)/V(128.22b) * Rd(1.08%) * (1-Tc(0.23)))
Discount Rate = 5.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.41%
[DCF Debug] Terminal Value 86.51% ; FCFF base≈8.91b ; Y1≈9.07b ; Y5≈9.94b
Fair Price DCF = 163.0 (EV 295.80b - Net Debt 22.23b = Equity 273.57b / Shares 1.68b; r=5.90% [WACC]; 5y FCF grow 1.52% → 2.90% )
EPS Correlation: 69.50 | EPS CAGR: 7.91% | SUE: 0.0 | # QB: 0
Revenue Correlation: -4.51 | Revenue CAGR: 0.86% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.25 | Chg30d=-0.001 | Revisions Net=-1 | Analysts=7
EPS next Year (2026-12-31): EPS=5.59 | Chg30d=+0.001 | Revisions Net=+1 | Growth EPS=+2.9% | Growth Revenue=-0.0%
Additional Sources for MO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle